| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 372 |
| 1 | AFLIBERCEPT | 273 |
| 2 | BEVACIZUMAB | 212 |
| 3 | BROLUCIZUMAB | 115 |
| 4 | FINGOLIMOD HCL | 68 |
| 5 | ADALIMUMAB | 67 |
| 6 | ASPIRIN | 67 |
| 7 | ASPIRIN 325 MG | 65 |
| 8 | ASPIRIN 81 MG | 65 |
| 9 | PREDNISONE | 45 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RANIBIZUMAB-NUNA | 3 | 0.0638 |
| 1 | ATORVALIQ | 1 | 0.0476 |
| 2 | BROLUCIZUMAB | 115 | 0.0315 |
| 3 | VERTEPORFIN FOR INJECTION | 41 | 0.0277 |
| 4 | PROPARACAINE HYDROCHLORIDE | 9 | 0.0169 |
| 5 | RANIBIZUMAB | 372 | 0.0140 |
| 6 | CEFUROXIME SODIUM | 15 | 0.0122 |
| 7 | TETRACAINE | 4 | 0.0101 |
| 8 | FLUORESCEIN SODIUM | 3 | 0.0097 |
| 9 | AFLIBERCEPT | 273 | 0.0087 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 728 |
| 1 | Corticosteroid [EPC] | 148 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 117 |
| 3 | Insulin Analog [EPC] | 70 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 68 |
| 5 | Kinase Inhibitor [EPC] | 55 |
| 6 | HMG-CoA Reductase Inhibitor [EPC] | 54 |
| 7 | Photoenhancer [EPC] | 41 |
| 8 | GLP-1 Receptor Agonist [EPC] | 37 |
| 9 | Proton Pump Inhibitor [EPC] | 37 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoenhancer [EPC] | 41 | 0.0105 |
| 1 | Antiseptic [EPC] | 19 | 0.0043 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 728 | 0.0039 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 12 | 0.0027 |
| 4 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 5 | Diagnostic Dye [EPC] | 1 | 0.0015 |
| 6 | Quinolone Antimicrobial [EPC] | 13 | 0.0013 |
| 7 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |
| 8 | Plasma Volume Expander [EPC] | 3 | 0.0010 |
| 9 | Anticholinergic [EPC] | 15 | 0.0009 |